Cargando…
Feasibility and safety of continuous retrograde administration of Del Nido cardioplegia: a case series
BACKGROUND: Del Nido (DN) cardioplegia, a calcium-free, hyperkalemic solution containing lidocaine and magnesium has been developed to help reduce intracellular calcium influx and the resulting myocyte damage in the immediate postischemic period following cardiac arrest. DN cardioplegia has been use...
Autores principales: | Najjar, Marc, George, Isaac, Akashi, Hirokazu, Nishimura, Takashi, Yerebakan, Halit, Mongero, Linda, Beck, James, Hill, Stephen C., Takayama, Hiroo, Williams, Mathew R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662002/ https://www.ncbi.nlm.nih.gov/pubmed/26612068 http://dx.doi.org/10.1186/s13019-015-0383-x |
Ejemplares similares
-
Del Nido Cardioplegia can be safely administered in high-risk coronary artery bypass grafting surgery after acute myocardial infarction: a propensity matched comparison
por: Yerebakan, Halit, et al.
Publicado: (2014) -
A novel dosing strategy of del Nido cardioplegia in aortic surgery
por: Chung, Megan M., et al.
Publicado: (2022) -
Re-dosing of del Nido cardioplegia in adult cardiac surgery requiring prolonged aortic cross-clamp
por: D’Angelo, Alex M, et al.
Publicado: (2021) -
Del Nido cardioplegia – what is the current evidence?
por: Sanetra, Krzysztof, et al.
Publicado: (2018) -
Effects of Del Nido cardioplegia on coronary bypass surgery
por: Bademci, Mehmet S, et al.
Publicado: (2022)